Breaking News Instant updates and real-time market news.

2021-03-05 11:12:26 TTWO Take-Two $170.42 / -3.03 (-1.75%) , MSFT Microsoft $227.70 / +0.84 (+0.37%) … 11:12 03/05/21 03/05 11:12 03/05/21 11:12	Take-Two CEO says players 'ready for $70 games,' VGC reports Take-Two (TTWO) CEO Strauss Zelnick reiterated his company's view that the move to charge $70 instead of $60 for the Xbox Series X (MSFT) and PlayStation 5 (SNE) versions of "NBA 2K21" was the right one, since the public was "ready" for the price hike, VGC's Chris Scullion reports, citing comments from the Morgan Stanley Technology, Media & Telecom Conference. "We announced a $70 price point for NBA 2K21, our view was that we're offering an array of extraordinary experiences, lots of replayability, and the last time there was a frontline price increase in the US was 2005, 2006, so we think consumers were ready for it," Zelnick said. The CEO did not seem to suggest, though, that all future games will cost $70 going forwards, instead saying the company needs to focus on providing a level of content that justifies that price point, the author notes. Reference Link TTWO Take-Two $170.42 / -3.03 (-1.75%) MSFT Microsoft $227.70 / +0.84 (+0.37%) SNE Sony $102.24 / +0.39 (+0.38%)	10 Mar
TTWO MSFT SNE TTWO Take-Two $170.42 / -3.03 (-1.75%) 02/09/21 Wells Fargo Take-Two price target raised to $235 from $205 at Wells Fargo 02/09/21 Wedbush Take-Two price target raised to $226 from $210 at Wedbush 02/09/21 Cowen Take-Two price target raised to $229 from $213 at Cowen 02/09/21 Credit Suisse Take-Two price target raised to $204 from $199 at Credit Suisse MSFT Microsoft $227.70 / +0.84 (+0.37%) 03/05/21 Morgan Stanley Microsoft price target raised to $290 from $285 at Morgan Stanley 03/03/21 Citi Microsoft assumed with a Buy at Citi 02/16/21 Wedbush Microsoft price target raised to $300 from $285 at Wedbush 02/16/21 UBS Workday price target raised to $280 from $235 at UBS SNE Sony $102.24 / +0.39 (+0.38%) 01/12/21 Citi Sony PS5 sales to date 'steady but somewhat disappointing,' says Citi 12/16/20 Benchmark Chicken Soup for the Soul price target raised to $25 from $20 at Benchmark 12/16/20 Craig-Hallum Chicken Soup for the Soul price target raised to $30 from $25 at Craig-Hallum 10/19/20 Credit Suisse Corsair Gaming initiated with an Outperform at Credit Suisse

2021-03-05 11:12:26

TTWO

Take-Two

$170.42 / -3.03 (-1.75%)

, MSFT

Microsoft

$227.70 / +0.84 (+0.37%)

… 11:12

03/05/21

03/05

11:12

03/05/21

11:12

Take-Two CEO says players 'ready for $70 games,' VGC reports

Take-Two (TTWO) CEO Strauss Zelnick reiterated his company's view that the move to charge $70 instead of $60 for the Xbox Series X (MSFT) and PlayStation 5 (SNE) versions of "NBA 2K21" was the right one, since the public was "ready" for the price hike, VGC's Chris Scullion reports, citing comments from the Morgan Stanley Technology, Media & Telecom Conference. "We announced a $70 price point for NBA 2K21, our view was that we're offering an array of extraordinary experiences, lots of replayability, and the last time there was a frontline price increase in the US was 2005, 2006, so we think consumers were ready for it," Zelnick said. The CEO did not seem to suggest, though, that all future games will cost $70 going forwards, instead saying the company needs to focus on providing a level of content that justifies that price point, the author notes. Reference Link

TTWO

Take-Two

$170.42 / -3.03 (-1.75%)

MSFT

Microsoft

$227.70 / +0.84 (+0.37%)

SNE

Sony

$102.24 / +0.39 (+0.38%)

10
Mar

TTWO
MSFT
SNE

TTWO Take-Two

$170.42 / -3.03 (-1.75%)

02/09/21 Wells Fargo: Take-Two price target raised to $235 from $205 at Wells Fargo

02/09/21 Wedbush: Take-Two price target raised to $226 from $210 at Wedbush

02/09/21 Cowen: Take-Two price target raised to $229 from $213 at Cowen

02/09/21 Credit Suisse: Take-Two price target raised to $204 from $199 at Credit Suisse

MSFT Microsoft

$227.70 / +0.84 (+0.37%)

03/05/21 Morgan Stanley: Microsoft price target raised to $290 from $285 at Morgan Stanley

03/03/21 Citi: Microsoft assumed with a Buy at Citi

02/16/21 Wedbush: Microsoft price target raised to $300 from $285 at Wedbush

02/16/21 UBS: Workday price target raised to $280 from $235 at UBS

SNE Sony

$102.24 / +0.39 (+0.38%)

01/12/21 Citi: Sony PS5 sales to date 'steady but somewhat disappointing,' says Citi

12/16/20 Benchmark: Chicken Soup for the Soul price target raised to $25 from $20 at Benchmark

12/16/20 Craig-Hallum: Chicken Soup for the Soul price target raised to $30 from $25 at Craig-Hallum

10/19/20 Credit Suisse: Corsair Gaming initiated with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

General news	Wall Street is enjoying a nice little rally » 14:25 04/23/21 04/23 14:25 04/23/21 14:25 $ECON Economic Data / + Wall Street is enjoying a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Recommendations	Zur Rose Group price target lowered to CHF 400 from CHF 500 at Berenberg » 14:24 04/23/21 04/23 14:24 04/23/21 14:24 ZRSEF Zur Rose Group $377.00 / + (+0.00%) Berenberg analyst Gerhard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ZRSEF Zur Rose Group $377.00 / + (+0.00%) 03/30/21 UBS Zur Rose Group price target lowered to CHF 260 from CHF 266 at UBS 03/23/21 Morgan Stanley Zur Rose Group initiated with an Overweight at Morgan Stanley 02/08/21 Berenberg Zur Rose Group price target raised to CHF 500 from CHF 300 at Berenberg 01/29/21 Citi Zur Rose Group downgraded to Neutral from Buy at Citi
Hot Stocks	Canada's NACI backs AstraZeneca vaccine for adults 30 and older, City News says » 14:24 04/23/21 04/23 14:24 04/23/21 14:24 AZN AstraZeneca $52.20 / -0.53 (-1.01%) The National Advisory… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $52.20 / -0.53 (-1.01%) 08:17 Today Vaxart appoints David Wheadon to its board of directors 04/20/21 EMA recommends clot warning for J&J vaccine, says benefit still positive 04/19/21 Emergent stops manufacturing at Baltimore facility after FDA inspection 04/16/21 AstraZeneca reports U.S. clearance of proposed acquisition of Alexion AZN AstraZeneca $52.20 / -0.53 (-1.01%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/12/21 Fly Intel: Top five analyst downgrades 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 04/12/21 Argus AstraZeneca downgraded to Hold from Buy at Argus AZN AstraZeneca $52.20 / -0.53 (-1.01%) 04/07/21 EMA says benefits of AstraZeneca Covid vaccine outweigh side effects 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage AZN AstraZeneca $52.20 / -0.53 (-1.01%) 04/21/21 EU snubs extra 300M J&J, AstraZeneca COVID vaccines, Reuters reports 04/20/21 J&J to cooperate in study of blood clots linked to COVID shot, Reuters says 04/18/21 Canada's Ontario to expand use of AstraZeneca COVID vaccine, Reuters says 04/16/21 J&J reached out to vaccine rivals to study blood clot risk, WSJ reports AZN AstraZeneca $52.20 / -0.53 (-1.01%) 04/16/21 Fly Intel: Wall Street's top stories for Friday 04/16/21 Fly Intel: Wall Street's top stories at midday 04/16/21 Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/30/21 AstraZeneca - AZN 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $52.20 / -0.53 (-1.01%) 04/22/21 AstraZeneca call volume above normal and directionally bullish 04/01/21 AstraZeneca put volume heavy and directionally bearish 03/22/21 AstraZeneca call volume above normal and directionally bullish 03/16/21 Unusually active option classes on open March 16th
Recommendations	Vonovia price target raised to EUR 66 from EUR 63 at Berenberg » 14:23 04/23/21 04/23 14:23 04/23/21 14:23 VNNVF Vonovia $68.20 / + (+0.00%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VNNVF Vonovia $68.20 / + (+0.00%) 03/16/21 RBC Capital Vonovia price target lowered to EUR 55 from EUR 59 at RBC Capital 03/09/21 Morgan Stanley Vonovia price target lowered to EUR 62 from EUR 63 at Morgan Stanley 03/08/21 Societe Generale Vonovia price target raised to EUR 69 from EUR 68.10 at Societe Generale 02/01/21 Barclays Vonovia price target raised to EUR 70 from EUR 65 at Barclays
Recommendations	Sandvik price target raised to SEK 265 from SEK 255 at Berenberg » 14:22 04/23/21 04/23 14:22 04/23/21 14:22 SDVKY Sandvik $26.69 / -0.57 (-2.09%) Berenberg analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SDVKY Sandvik $26.69 / -0.57 (-2.09%) 01/15/21 Sandvik AB acquires minority stake in Oqton, terms undisclosed 12/24/20 Sandvik to acquire DSI Underground for approx. EUR943M SDVKY Sandvik $26.69 / -0.57 (-2.09%) 04/22/21 RBC Capital Sandvik price target raised to SEK 230 from SEK 210 at RBC Capital 04/21/21 Credit Suisse Sandvik price target raised to SEK 275 from SEK 270 at Credit Suisse 04/21/21 Morgan Stanley Sandvik price target raised to SEK 247 from SEK 238 at Morgan Stanley 04/21/21 Deutsche Bank Sandvik price target raised to SEK 280 from SEK 275 at Deutsche Bank

Recommendations	Knorr-Bremse price target raised to EUR 115 from EUR 111 at Berenberg » 14:20 04/23/21 04/23 14:20 04/23/21 14:20 KNRRY Knorr-Bremse $30.91 / -0.12 (-0.39%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KNRRY Knorr-Bremse $30.91 / -0.12 (-0.39%) 04/06/21 JPMorgan Knorr-Bremse price target lowered to EUR 107 from EUR 110 at JPMorgan 03/05/21 Societe Generale Knorr-Bremse price target lowered to EUR 124 from EUR 126 at Societe Generale 01/12/21 Deutsche Bank Knorr-Bremse price target raised to EUR 115 from EUR 107 at Deutsche Bank 12/11/20 Credit Suisse Knorr-Bremse price target raised to EUR 94 from EUR 89 at Credit Suisse
Recommendations	Grand City Properties price target raised to EUR 26 from EUR 25 at Berenberg » 14:20 04/23/21 04/23 14:20 04/23/21 14:20 GRNNF Grand City Properties $26.55 / + (+0.00%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GRNNF Grand City Properties $26.55 / + (+0.00%) 04/20/21 JPMorgan Grand City Properties price target raised to EUR 26 from EUR 24.50 at JPMorgan 03/16/21 Deutsche Bank Grand City Properties price target lowered to EUR 23 at Deutsche Bank 02/01/21 Barclays Grand City Properties upgraded to Overweight from Equal Weight at Barclays 12/07/20 HSBC Grand City Properties downgraded to Hold from Buy at HSBC
Recommendations	Domino's Pizza Group price target raised to 300 GBp from 250 GBp at Berenberg » 14:20 04/23/21 04/23 14:20 04/23/21 14:20 DPUKY Domino's Pizza Group $10.20 / -0.05 (-0.49%) Berenberg analyst Ned… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DPUKY Domino's Pizza Group $10.20 / -0.05 (-0.49%) 03/16/21 Barclays Domino's Pizza Group price target raised to 380 GBp from 350 GBp at Barclays 12/09/20 Peel Hunt Domino's Pizza Group upgraded to Buy from Add at Peel Hunt 11/10/20 Barclays Domino's Pizza Group reinstated with an Equal Weight at Barclays 08/05/20 Peel Hunt Domino's Pizza Group downgraded to Add from Buy at Peel Hunt
Recommendations	Deutsche Wohnen price target raised to EUR 52 from EUR 43 at Berenberg » 14:19 04/23/21 04/23 14:19 04/23/21 14:19 DTCWY Deutsche Wohnen $27.85 / +0.375 (+1.37%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DTCWY Deutsche Wohnen $27.85 / +0.375 (+1.37%) 05:09 Today Exane BNP Paribas Deutsche Wohnen downgraded to Underperform from Neutral at Exane BNP Paribas 04/19/21 RBC Capital Deutsche Wohnen price target raised to EUR 53 from EUR 49 at RBC Capital 04/16/21 Barclays Deutsche Wohnen price target raised to EUR 55 from EUR 47 at Barclays 04/16/21 JPMorgan Deutsche Wohnen price target raised to EUR 51 from EUR 43 at JPMorgan
Periodicals	Apple rolls out program for employees to get COVID-19 vaccine, Bloomberg says » 14:19 04/23/21 04/23 14:19 04/23/21 14:19 AAPL Apple $134.72 / +2.76 (+2.09%) , WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) Apple (AAPL) is rolling… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 13:07 Today Microsoft releases preview version of Office 2021 for Mac, Office LTSC 04/21/21 Twitter to let users tweet images in 4K on Android, iOS 04/20/21 Apple introduces new iPad Pro with M1 chip, 12.9-inch Liquid Retina XDR display 04/20/21 Apple says 11-inch iPad Pro starts at $799, available in second half of May WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 04/19/21 Walgreens Boots Alliance enters agreement with Abbott to sell BinaxNOW 04/19/21 Abbott begins shipping BinaxNOW COVID-19 Ag Self Test to retailers 04/12/21 Walgreens now administering Covid vaccinations in 49 states 04/07/21 Uber launching $250M driver stimulus program AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 04/21/21 Morgan Stanley Apple shares 'on path to re-rate,' says Morgan Stanley 04/21/21 Canaccord Apple refreshed product line supports positive thesis, says Canaccord 04/21/21 Bernstein Apple event broader in scope than anticipated, says Bernstein 04/21/21 Atlantic Equities Apple making push to fight Spotify for podcast creators, says Atlantic Equities WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 04/14/21 Morgan Stanley Walgreens Boots Alliance price target raised to $60 from $52 at Morgan Stanley 04/08/21 Citi Walgreens Boots Alliance price target raised to $60 from $50 at Citi 04/05/21 Barclays Walgreens Boots Alliance price target raised to $55 from $47 at Barclays 04/01/21 RBC Capital Walgreens Boots Alliance price target raised to $52 from $44 at RBC Capital AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 03/31/21 Walgreens Boots Alliance raises FY21 EPS view to up mid-to-high single digits 03/31/21 Walgreens Boots Alliance reports Q2 total adjusted EPS $1.40, consensus $1.11 03/30/21 Notable companies reporting before tomorrow's open 03/30/21 Notable companies reporting before tomorrow's open AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 13:14 Today Spotify plans to announce podcast subscription offering next week, WSJ reports 06:14 Today Apple's new iPad Pros to boost Foxconn's April revenues, DigiTimes reports 04/22/21 Apple preparing notifications, Home Screen updates for iOS 15, Bloomberg says 04/22/21 Apple planning to expand App Store advertising business, FT reports WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 04/05/21 Walgreens to change vaccine scheduling to comply with guidelines, NYT reports 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says 01/26/21 Walgreens to name Starbucks executive Roz Brewer as CEO, WSJ says AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 04/22/21 Fly Intel: What to watch in Intel's earnings report 04/21/21 #SocialStocks: House committee looks to rein in Big Tech 04/20/21 Fly Intel: Wall Street's top stories for Tuesday 04/14/21 #SocialStocks: Facebook removes 16,000 trading groups with fake product reviews WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 03/31/21 Fly Intel: Wall Street's top stories for Wednesday 03/31/21 Fly Intel: Wall Street's top stories at midday 03/31/21 Fly Intel: Pre-market Movers 03/16/21 Fly Intel: Wall Street's top stories for Tuesday 05/04/21 IT Hardware & Communications 04/28/21 Apple - AAPL AAPL WBA AAPL Apple $134.72 / +2.76 (+2.09%) 04/22/21 Notable open interest changes for April 22nd 04/21/21 Notable open interest changes for April 21st 04/19/21 Notable open interest changes for April 19th 04/15/21 Notable open interest changes for April 15th WBA Walgreens Boots Alliance $53.04 / +0.45 (+0.86%) 03/31/21 Early notable gainers among liquid option names on March 31st 03/31/21 Unusually active option classes on open March 31st 03/15/21 Walgreen Boots call volume above normal and directionally bullish 03/12/21 Walgreen Boots call volume above normal and directionally bullish

Technical Analysis	NASDAQ market internals summary » 14:17 04/23/21 04/23 14:17 04/23/21 14:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 14:16 04/23/21 04/23 14:16 04/23/21 14:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary
Periodicals	Kansas City Southern likely to hold talks with Canadian National, Bloomberg says » 14:13 04/23/21 04/23 14:13 04/23/21 14:13 KSU Kansas City Southern $298.60 / +1.95 (+0.66%) , CNI Canadian National $109.89 / +0.01 (+0.01%) , CP Canadian Pacific $368.27 / +0.78 (+0.21%) Kansas City Southern… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSU CNI CP KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 08:34 Today CN files letter with Surface Transportation Board on KCS proposal 04/22/21 CN sends letter to Kansas City Southern board regarding 'superior' proposal 04/21/21 North American rail traffic rose 28% in week ended April 17, AAR says 04/21/21 CN submits prefiling notice of intent with Surface Transportation Board CNI Canadian National $109.89 / +0.01 (+0.01%) 08:34 Today CN files letter with Surface Transportation Board on KCS proposal 04/22/21 CN sends letter to Kansas City Southern board regarding 'superior' proposal 04/21/21 North American rail traffic rose 28% in week ended April 17, AAR says 04/21/21 CN submits prefiling notice of intent with Surface Transportation Board CP Canadian Pacific $368.27 / +0.78 (+0.21%) 08:34 Today CN files letter with Surface Transportation Board on KCS proposal 04/22/21 CN sends letter to Kansas City Southern board regarding 'superior' proposal 04/21/21 Canadian Pacific reports Q1 operating ratio 60.2%, up 100bps from last year 04/21/21 Canadian Pacific shareholders approve five-for-one share split KSU CNI CP KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 04/22/21 Credit Suisse Canadian Pacific not planning to preemptively raise bid, says Credit Suisse 04/22/21 Susquehanna Canadian Pacific price target raised to $403 from $402 at Susquehanna 04/21/21 National Bank Canadian Pacific price target lowered to C$511 from C$515 at National Bank 04/19/21 Raymond James Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James CNI Canadian National $109.89 / +0.01 (+0.01%) 04/22/21 Credit Suisse Canadian Pacific not planning to preemptively raise bid, says Credit Suisse 04/22/21 Susquehanna Canadian Pacific price target raised to $403 from $402 at Susquehanna 04/21/21 National Bank Canadian National price target lowered to C$143 from C$147 at National Bank 04/21/21 Scotiabank Canadian National price target lowered to C$143 from C$145 at Scotiabank CP Canadian Pacific $368.27 / +0.78 (+0.21%) 12:03 Today Desjardins Canadian Pacific price target raised to C$529 from C$525 at Desjardins 04/22/21 National Bank Canadian Pacific price target lowered to C$511 from C$515 at National Bank 04/22/21 Credit Suisse Canadian Pacific not planning to preemptively raise bid, says Credit Suisse 04/22/21 TD Securities Canadian Pacific price target lowered to C$525 from C$540 at TD Securities KSU CNI CP KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 04/16/21 Kansas City Southern reports Q1 EPS $1.68, consensus $1.94 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 CNI Canadian National $109.89 / +0.01 (+0.01%) 01/26/21 Canadian National sees FY21 adjusted EPS up high-single digits 01/26/21 Canadian National reports Q4 adjusted EPS C$1.43 vs. C$1.25 last year CP Canadian Pacific $368.27 / +0.78 (+0.21%) 04/21/21 Canadian Pacific sees FY21 adjusted EPS growth in double digits y-o-y 04/21/21 Canadian Pacific reports Q1 EPS C$4.48 vs. C$4.42 a year ago 01/27/21 Canadian Pacific sees FY21 double-digit adjusted diluted EPS growth 01/27/21 Canadian Pacific reports Q4 adjusted EPS C$5.06 vs. C$4.77 last year KSU KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports KSU CNI CP KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 04/20/21 Fly Intel: Wall Street's top stories for Tuesday 04/20/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Fly Intel: Pre-market Movers 03/22/21 Fly Intel: Wall Street's top stories for Monday CNI Canadian National $109.89 / +0.01 (+0.01%) 04/20/21 Fly Intel: Wall Street's top stories for Tuesday 04/20/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Fly Intel: Pre-market Movers CP Canadian Pacific $368.27 / +0.78 (+0.21%) 04/21/21 Fly Intel: After-Hours Movers 04/20/21 Fly Intel: Wall Street's top stories for Tuesday 04/20/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Fly Intel: Pre-market Movers 04/26/21 Canadian National - CNI 05/20/21 Kansas City Southern KSU KSU Kansas City Southern $298.60 / +1.95 (+0.66%) 04/20/21 Early notable gainers among liquid option names on April 20th 03/22/21 Early notable gainers among liquid option names on March 22nd
Recommendations	Volvo price target raised to SEK 300 from SEK 288 at Citi » 14:08 04/23/21 04/23 14:08 04/23/21 14:08 VLVLY Volvo $24.70 / +0.3625 (+1.49%) Citi analyst Klas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research VLVLY Volvo $24.70 / +0.3625 (+1.49%) 04/08/21 Volvo, SSAB sign collaboration agreement to make vehicles from fossil-free steel 04/07/21 Volvo Group selects BlackBerry QNX for dynamic software platform 03/30/21 Volvo Autonomous partners with Aurora on autonomous transport solutions 03/22/21 Volvo says shortage of semiconductors impacting production VLVLY Volvo $24.70 / +0.3625 (+1.49%) 04/07/21 Societe Generale Societe Generale says Volvo strategy underappreciated, upgrades to Buy 04/07/21 Societe Generale Volvo AB upgraded to Buy from Hold at Societe Generale 01/14/21 R.F. Lafferty Luminar initiated with a Buy at R.F. Lafferty 01/13/21 UBS Volvo AB price target raised to SEK 210 from SEK 194 at UBS
Recommendations	Thales price target raised to EUR 100 at Citi » 14:07 04/23/21 04/23 14:07 04/23/21 14:07 THLLY Thales $20.53 / +0.27 (+1.33%) Citi analyst Pavan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THLLY Thales $20.53 / +0.27 (+1.33%) 04/01/21 Deutsche Bank Thales price target raised to EUR 98 from EUR 93 at Deutsche Bank 03/10/21 JPMorgan Thales price target raised to EUR 100 from EUR 97 at JPMorgan 03/10/21 Societe Generale Thales price target raised to EUR 93 from EUR 83 at Societe Generale 03/08/21 Barclays Thales price target raised to EUR 87 from EUR 85 at Barclays

Upgrade	CAE upgraded to Outperformer from Neutral at CIBC » 14:01 04/23/21 04/23 14:01 04/23/21 14:01 CAE CAE $30.15 / +0.54 (+1.82%) CIBC analyst Kevin Chiang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events CAE CAE $30.15 / +0.54 (+1.82%) 03/01/21 CAE to acquire L3Harris Technologies military training business for $1.05B 03/01/21 L3Harris Technologies to sell Military Training, Combat Propulsion for $1.45B 02/12/21 CAE sees 2021 CapEx $100M 02/02/21 CAE signs contract with Pyure to assemble anti-COVID-19 air sanitizers CAE CAE $30.15 / +0.54 (+1.82%) 13:55 Today CIBC CAE upgraded to Outperformer from Neutral at CIBC 04/20/21 Fly Intel: Top five analyst upgrades 04/20/21 National Bank CAE upgraded to Outperform on Civil unit rebound at National Bank 04/19/21 National Bank CAE upgraded to Outperform from Sector Perform at National Bank CAE CAE $30.15 / +0.54 (+1.82%) 02/12/21 CAE reports Q3 EPS ex-items C$0.22 vs. C$0.37 a year ago 11/10/20 CAE reports Q2 EPS C$0.13 vs. C$0.28 a year ago 10 Mar CAE CAE $30.15 / +0.54 (+1.82%) 02/28/21 CAE near deal to acquire L3Harris military-training unit, WSJ reports CAE CAE $30.15 / +0.54 (+1.82%) 11/16/20 Fly Intel: After-Hours Movers 05/19/21 CAE - CAE
Options	Porch Group put volume heavy and directionally bearish » 13:55 04/23/21 04/23 13:55 04/23/21 13:55 PRCH Porch.com $13.10 / -0.16 (-1.21%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PRCH Porch.com $13.10 / -0.16 (-1.21%) 04/22/21 Metromile announces appointment of Regi Vengalil as Chief Financial Officer 04/19/21 Porch.com completes redemption of public warrants 04/06/21 Porch Group completes acquisition of Homeowners of America, $100M deal 03/23/21 Porch.com announces redemption of public warrants PRCH Porch.com $13.10 / -0.16 (-1.21%) 03/26/21 Craig-Hallum Porch.com initiated with a Buy at Craig-Hallum 01/15/21 Northland Porch.com price target raised to $25 from $17 at Northland 12/29/20 Benchmark Benchmark starts Porch.com at Buy with $24 price target 12/29/20 Benchmark Porch.com initiated with a Buy at Benchmark PRCH Porch.com $13.10 / -0.16 (-1.21%) 01/14/21 Porch.com sees FY21 revenue $120M-$170M, two estimates $120.06M 01/14/21 Porch sees FY20 revenue over $72M, two estimates $73.24M PRCH Porch.com $13.10 / -0.16 (-1.21%) 04/08/21 Spruce Point short Porch Group, sees up to 70% downside for shares 04/08/21 Spruce Point issues short report on Porch.com, sees 70% downside risk PRCH Porch.com $13.10 / -0.16 (-1.21%) 01/14/21 Fly Intel: After-Hours Movers PRCH Porch.com $13.10 / -0.16 (-1.21%) 04/07/21 Largest borrow rate increases among liquid names 01/13/21 Thirteen new option listings and two option delistings on January 13th
Recommendations	Oppenheimer still bullish on Inovio after U.S. discontinues trial funding » 13:53 04/23/21 04/23 13:53 04/23/21 13:53 INO Inovio $6.88 / -2.255 (-24.70%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options INO Inovio $6.88 / -2.255 (-24.70%) 08:15 Today Inovio sinks after Department of Defense stops vaccine trial funding 08:05 Today Inovio planning for ex-U.S. global Phase 3 trial for INO-4800 04/15/21 Inovio's COVID-19 vaccine candidate shows response against all tested variants 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints INO Inovio $6.88 / -2.255 (-24.70%) 09:47 Today Piper Sandler Piper 'incrementally cautious' on Inovio, says today's selloff appropriate 03/23/21 Fly Intel: Top five analyst initiations 03/23/21 BofA Inovio initiated with a Neutral at BofA 03/02/21 Piper Sandler Piper lowers Inovio target to $7 after 'decidedly negative' update INO Inovio $6.88 / -2.255 (-24.70%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $6.88 / -2.255 (-24.70%) 12:17 Today Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 05/13/21 Inovio Pharmaceuticals, Inc INO Inovio $6.88 / -2.255 (-24.70%) 04/20/21 Largest borrow rate increases among liquid names 04/15/21 Unusually active option classes on open April 15th 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish
Recommendations	Gjensidige price target lowered to NOK 216 from NOK 226 at Credit Suisse » 13:51 04/23/21 04/23 13:51 04/23/21 13:51 GJNSY Gjensidige $24.80 / +0.3 (+1.22%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GJNSY Gjensidige $24.80 / +0.3 (+1.22%) 04/21/21 Barclays Gjensidige price target raised to NOK 200 from NOK 198 at Barclays 03/30/21 Barclays Gjensidige price target raised to NOK 198 from NOK 195 at Barclays 02/12/21 Nordea Gjensidige upgraded to Buy from Hold at Nordea 01/27/21 Morgan Stanley Gjensidige price target raised to NOK 180 from NOK 175 at Morgan Stanley
Recommendations	Pernod Ricard price target raised to EUR 183 from EUR 172 at Credit Suisse » 13:51 04/23/21 04/23 13:51 04/23/21 13:51 PDRDY Pernod Ricard $42.05 / +0.19 (+0.45%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PDRDY Pernod Ricard $42.05 / +0.19 (+0.45%) 12:47 Today Deutsche Bank Pernod Ricard price target raised to EUR 205 from EUR 200 at Deutsche Bank 04/09/21 Barclays Pernod Ricard price target raised to EUR 195 from EUR 194 at Barclays 02/12/21 Barclays Pernod Ricard price target raised to EUR 194 from EUR 185 at Barclays 02/12/21 Deutsche Bank Pernod Ricard price target raised to EUR 200 from EUR 189 at Deutsche Bank

Hot Stocks	ADC Therapeutics granted FDA approval for Zynlonta BLA » 13:50 04/23/21 04/23 13:50 04/23/21 13:50 ADCT ADC Therapeutics $25.35 / +0.91 (+3.72%) According to a post to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events ADCT ADC Therapeutics $25.35 / +0.91 (+3.72%) 04/06/21 Overland ADCT BioPharma appoints Eric Koo as CEO 03/17/21 ADC Therapeutics rises 7.5% 02/04/21 ADC Therapeutics completes enrollment in camidanlumab tesirine trial 01/07/21 ADC Therapeutics announces EAP for loncastuximab tesirine for certain patients ADCT ADC Therapeutics $25.35 / +0.91 (+3.72%) 03/19/21 H.C. Wainwright ADC Therapeutics price target raised to $48 from $47 at H.C. Wainwright 12/02/20 Stifel ADC Therapeutics initiated with a Hold at Stifel 10/29/20 Fly Intel: Top five analyst initiations 10/29/20 H.C. Wainwright ADC Therapeutics initiated with a Buy at H.C. Wainwright ADCT ADC Therapeutics $25.35 / +0.91 (+3.72%) 03/18/21 ADC Therapeutics reports Q4 adjusted EPS (82c), consensus (38c) 03/18/21 ADC Therapeutics reports Q4 EPS (73c), consensus (38c) 11/12/20 ADC Therapeutics reports Q3 EPS (58c), consensus (81c ) 24 Sep 15 May 05/21/21 PDUFA Date for Loncastuximab Tesirine
Recommendations	Umicore price target raised to EUR 33 from EUR 30 at Credit Suisse » 13:50 04/23/21 04/23 13:50 04/23/21 13:50 UMICY Umicore $14.97 / +0.63 (+4.39%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UMICY Umicore $14.97 / +0.63 (+4.39%) 12:45 Today Deutsche Bank Umicore price target raised to EUR 50 from EUR 46 at Deutsche Bank 12:41 Today JPMorgan Umicore price target raised to EUR 35 from EUR 30 at JPMorgan 03/09/21 JPMorgan Umicore added to Analyst Focus List as Short at JPMorgan 02/12/21 Berenberg Umicore price target raised to EUR 56 from EUR 50 at Berenberg
Recommendations	UPM-Kymmene price target raised to EUR 33.50 from EUR 32.25 at Credit Suisse » 13:49 04/23/21 04/23 13:49 04/23/21 13:49 UPMMY UPM-Kymmene $38.99 / -0.255 (-0.65%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research UPMMY UPM-Kymmene $38.99 / -0.255 (-0.65%) 04/16/21 UBS UPM-Kymmene price target raised to EUR 32.10 from EUR 30.80 at UBS 01/26/21 DNB Markets UPM-Kymmene downgraded to Hold from Buy at DNB Markets 01/12/21 UBS UPM-Kymmene downgraded to Neutral from Buy at UBS 01/05/21 Jefferies UPM-Kymmene downgraded to Underperform from Hold at Jefferies
Recommendations	Relx price target raised to 2,114 GBp from 2,085 GBp at Credit Suisse » 13:49 04/23/21 04/23 13:49 04/23/21 13:49 RELX Relx $27.07 / +0.19 (+0.71%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RELX Relx $27.07 / +0.19 (+0.71%) 03/01/21 Deutsche Bank Relx price target lowered to 1,790 GBp from 1,850 GBp at Deutsche Bank 02/19/21 Morgan Stanley Relx price target raised to 2,100 GBp from 2,000 GBp at Morgan Stanley 02/12/21 Barclays Relx price target raised to 2,090 GBp from 2,070 GBp at Barclays 01/29/21 Barclays Relx price target raised to 2,070 GBp from 1,985 GBp at Barclays
Recommendations	Nestle price target raised to CHF 110 from CHF 105 at Credit Suisse » 13:48 04/23/21 04/23 13:48 04/23/21 13:48 NSRGY Nestle $119.71 / +2.78 (+2.38%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals NSRGY Nestle $119.71 / +2.78 (+2.38%) 04/22/21 Nestle still sees increase in organic sales growth towards MSD rate in 2021 03/30/21 XPO Logistics, Nestle unveil UK digital distribution warehouse 02/18/21 Nestle sees sustained mid single-digit organic sales growth in mid-term 02/18/21 Nestle sees increase in organic sales growth towards MSD rate in 2021 NSRGY Nestle $119.71 / +2.78 (+2.38%) 03/17/21 Morgan Stanley Nestle price target raised to CHF 115 from CHF 112 at Morgan Stanley 03/02/21 AlphaValue Nestle upgraded to Buy from Add at AlphaValue 02/26/21 Morgan Stanley Nestle assumed with an Overweight at Morgan Stanley 02/22/21 Berenberg Nestle price target lowered to CHF 120 from CHF 122 at Berenberg NSRGY Nestle $119.71 / +2.78 (+2.38%) 04/22/21 Nestle reports three-month sales CHF 21.089B vs. CHF 20.812B last year 02/25/21 Aimmune presents new data in patients treated with Palforzia for peanut allergy 02/18/21 Nestle reports FY20 sales CHF84.343B vs. CHF92.568B last year NSRGY Nestle $119.71 / +2.78 (+2.38%) 12:21 Today Nestle in talks to buy vitamin maker Bountiful, WSJ reports 04/22/21 Nestle CEO tells CNBC company maintaining growth amid sustainability push 04/22/21 Danimer Scientific falls after Spruce Point predicts 65% share downside 02/02/21 Nestle nears deal to sell North American bottled water business, Reuters says

Events

Earnings calls, analyst events, roadshows and more

PPD
Today at 16:00

PPD, Inc. Firm Sponsored Meetings
IBN
Tomorrow at 09:15

ICICI Bank - IBN Conference Calls
FAST
Tomorrow at 11:00

Fastenal Co. Firm Sponsored Meetings
PKX
2021-04-25 at 22:00

Posco - PKX Conference Calls
SLGL
2021-04-26 at 00:00

PDUFA Date for Epsolay (benzoyl peroxide, 5%, cream) Government Event
2021-04-26 at 00:00

Biden’s Infrastructure Plan and Alternatives Virtual Policy Forum Conferences

Virtual Forum
FBIO
2021-04-26 at 00:00

FuboTV Firm Sponsored Meetings

Virtual Meeting
USB
2021-04-26 at 00:00

U.S. Bancorp Firm Sponsored Meetings

Virtual Meeting
2021-04-26 at 00:00

Energy Industry Meetings

Virtual Meeting
CAJ
2021-04-26 at 05:00

Canon - CAJ Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One Priced at: $27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham Priced at: $56.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler Priced at: $14.00 6.96M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong Priced at: $130.00 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim Priced at: $150.00 4.78M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NOTV X NOTV Inotiv Spot Secondary Managers: Colliers Priced at: $17.00 2.647M Shares
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR Priced at: $16.00 9.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink Priced at: $17.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA Priced at: $31.00 16.13M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EOLS X EOLS Evolus Spot Secondary Managers: SVB Leerink, Stifel & Cantor Fitzgerald Priced at: $9.50 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NBSE X NBSE NeuBase Therapeutics Spot Secondary Managers: RBC Capital, Oppenheimer & Chardan, National Securities Priced at: $5.00 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB Priced at: $14.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush Priced at: $15.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim Priced at: $17.00 7.353M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist Priced at: $19.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel Priced at: $17.00 11.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDAP X EDAP EDAP TMS Spot Secondary Managers: Piper Sandler Priced at: $6.75 4.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Take-Two CEO says players 'ready for $70 games,' VGC reports

TODAY'S FREE FLY STORIES

Get Full Fly Access